BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37301537)

  • 1. Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1 Promotes the Progression of Invasive Micropapillary Carcinoma of the Breast and Predicts a Poor Prognosis.
    Wu K; Li W; Liu H; Niu C; Shi Q; Zhang J; Gao G; Sun H; Liu F; Fu L
    Am J Pathol; 2023 Sep; 193(9):1267-1283. PubMed ID: 37301537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast.
    Zhi R; Wu K; Zhang J; Liu H; Niu C; Li S; Fu L
    Cancer Sci; 2023 May; 114(5):1912-1928. PubMed ID: 36637351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
    Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
    Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive micropapillary carcinoma of the breast had poor clinical characteristics but showed no difference in prognosis compared with invasive ductal carcinoma.
    Li G; Yang S; Yao J; Wang Z; Yao G; Liu M; Ye C
    World J Surg Oncol; 2016 Aug; 14(1):207. PubMed ID: 27492008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Features and Prognosis of Invasive Micropapillary Carcinoma Compared to Invasive Ductal Carcinoma-NOS: Worse or Better?
    Aker FV; Ekren E; Dogan M; Gurleyik G; Tanrikulu E; Oven BB
    J Coll Physicians Surg Pak; 2022 Sep; 32(9):1196-1201. PubMed ID: 36089720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PSCA expression in invasive micropapillary carcinoma of breast].
    Hao JY; Yang YL; Li S; Qian XL; Liu FF; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):382-6. PubMed ID: 21914346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
    Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
    PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis.
    Wu Y; Zhang N; Yang Q
    BMC Cancer; 2017 Dec; 17(1):839. PubMed ID: 29228910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The comparison of characters between invasive micropapillary carcinoma and invasive ductal carcinoma not otherwise specified of the breast].
    Hua B; Lu X; Xiao WZ; He SR; Wang Z
    Zhonghua Wai Ke Za Zhi; 2017 Oct; 55(10):770-774. PubMed ID: 29050179
    [No Abstract]   [Full Text] [Related]  

  • 11. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
    Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
    Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
    Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
    BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in breast: A meta-analysis of PSM studies.
    Ye F; Yu P; Li N; Yang A; Xie X; Tang H; Liu P
    Breast; 2020 Jun; 51():11-20. PubMed ID: 32172190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of TNF-alpha and TNFRII in invasive micropapillary carcinoma of the breast: clinicopathological correlations.
    Cui LF; Guo XJ; Wei J; Liu FF; Fan Y; Lang RG; Gu F; Zhang XM; Fu L
    Histopathology; 2008 Oct; 53(4):381-8. PubMed ID: 18764880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome.
    Ren M; Liu F; Zhu Y; Li Y; Lang R; Fan Y; Gu F; Zhang X; Fu L
    Virchows Arch; 2014 Sep; 465(3):291-8. PubMed ID: 24980157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
    Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study.
    Yu JI; Choi DH; Park W; Huh SJ; Cho EY; Lim YH; Ahn JS; Yang JH; Nam SJ
    Breast; 2010 Jun; 19(3):231-7. PubMed ID: 20304650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive micropapillary carcinoma of the breast had no difference in prognosis compared with invasive ductal carcinoma: a propensity-matched analysis.
    Hao S; Zhao YY; Peng JJ; Ren F; Yang WT; Yu KD; Shao ZM
    Sci Rep; 2019 Jan; 9(1):286. PubMed ID: 30670771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of invasive micropapillary carcinoma of the breast.
    Tang SL; Yang JQ; Du ZG; Tan QW; Zhou YT; Zhang D; Lv Q
    Oncotarget; 2017 Jun; 8(26):42455-42465. PubMed ID: 28418916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.